Audited Quarterly Results for the Year ended 31st March, 2001
(Rs.in Mio)
Particulars
Year ended 31.03.2001
Year ended 31.03.2000
Income
Net Sales
9,961.0
7,456.1
Other Income
11.65
34.7
Total Income
10,077.5
7,490.8
Total expenditure
a. (Increase) / Decrease in Stock in
Trade
(472.4)
63.4
b. Materials Consumed
6,968.4
4,674.2
c. Staff Cost
216.2
156.9
d. Other Expenditure
1,966.4
1,389.2
Gross Profit (PBDIT)
1,398.9
1,207.1
Interest
416.8
294.0
Depreciation
147.8
95.2
Profit Before Tax
834.3
817.9
Provision for Taxation
151.2
71.9
Net Profit
683.1
746.0
Paid-up Equity Share Capital
202.0*
100.0
Reserves excluding Revaluation Reserves
2,564.1
2,007.1
Earnings per Share (Rs.)
33.82
74.59
Aggregate of Non-promoter Shareholding
- No. of Shares
73,76,960
- % of Shareholding
36.88
* Post bonus & post merger equity
Notes:
1.
The above results were approved by the Board of Directors in its meeting held on 29.06.2001
2.
The Board has recommended a dividend of 30% for the year 2000-01
3.
The above results are not comparable with that of previous year:
a)
as they include the results of Sri Chakra Remedies Limited, with an overall loss of Rs.7.20 crore, pursuant to the approval of Scheme of Amalgamation by the Hon'ble Court of A.P
b)
The company has changed its accounting policies in line with prudent and conservative norms, ultimately leading to adoption of US GAAP, consequent to which the profits are lower by Rs.15.21 crore.
c)
The company is availing the guidance of S.R.Batliboi & Co., a member firm of Emst & Young International in this exercise
4.
In view of Amalgamation of Sri Chakra Remedies Limited, the Company is in the process of issuing 1,98,000 equity shares of Rs.10 each as fully paid to the erstwhile shareholders of Sri Chakra Remedies Limited
